Sanjay Chanda, SVP, Drug Development at Anacor Pharmaceuticals, Inc. (ANAC), sold 5,000 shares at $45.00 ($225K) on 2015-03-04, disclosed to the SEC on 2015-03-04.
Scheduled sale ($225k) by SVP, Drug Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 48 | $2K | 1.0% |
| 2 | $45.00 | 4,952 | $223K | 99.0% |
| Total | $45.00 avg | 5,000 | $225K | 100% |
| Filing → |
| ANAC | SELL | 2014-12-01 | $175K | — | Filing → |
| ANAC | SELL | 2014-09-12 | $243K | — | Filing → |